3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
6
Carcinoma, Renal Cell
5
Carcinoma, Transitional Cell
3
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Clear-cell metastatic renal cell carcinoma
2
Vulvar Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Somatostatinoma
1
Seminoma
1
Sarcoma
1
Rectal Neoplasms
1
Rare Diseases
1
Pseudomyxoma Peritonei
1
Pheochromocytoma
1
Perivascular Epithelioid Cell Neoplasms
1
Penile Neoplasms
1
Parathyroid Neoplasms
1
Paranasal Sinus Neoplasms
1
Paraganglioma
1
Paget Disease, Extramammary
1
Ovarian Neoplasms
1
Osteosarcoma
1
Interventions
Rituximab
15
Cyclophosphamide
15
Prednisone
11
Doxorubicin
10
Vincristine
7
Lenalidomide
7
ibrutinib
6
polatuzumab vedotin
4
obinutuzumab
4
glofitamab
4
fludarabine
4
Oxaliplatin
4
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
venetoclax
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Specimen Handling
3
R-CHOP protocol
3
Etoposide
3
Cyclosporine
3
Biopsy
3
zanubrutinib
2
prednylidene
2
pembrolizumab
2
deltacortene
2
acalabrutinib
2
Prednisolone
2
Mycophenolic Acid
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
CTLA-4 Antigen
×
30 days
×
Clear all
No trials found.